TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. We are applying cutting-edge synthetic biology techniques to produce a class of plant compounds, called diterpenoids, via fermentation. This will enable novel applications of plant diterpenoids and revolutionize a range of industries - while avoiding intensive plant farming and petrochemicals. Our first product will liberate the world from rat poison, by supporting safe rat sex.
| Website | http://www.triptobio.com/ |
| Employees | 8 (8 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology Platform, Plant Cell Culture, Biomanufacturing, Natural Ingredients, Natural Product Development, Sustainable Agriculture, Plant Extracts, Green Chemistry, Bio-Based Products, Botanical Extracts, Plant Science, Plant Health, Renewable Resources, Agricultural Technology, Eco-Friendly Production, Plant Derived Materials, Sustainable Solutions, Environmental Sustainability, Responsible Sourcing |
| Competitors | Johnson & Johnson, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Illumina, Alnylam Pharmaceuticals, Amgen, CureVac, Sangamo Therapeutics, Inc., Moderna Therapeutics +45 more (view full list) |
Looking for a particular TriptoBIO employee's phone or email?
Jon Christensen is the Co-Founder of TriptoBIO.
8 people are employed at TriptoBIO.